Saturday 17 October 2026
Export CCLD’s income statement to Excel — free account
CareCloud, Inc.
CCLD Healthcare Health Information Services
CareCloud, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $120.5 million, up 8.72% from fiscal 2024. In the quarter to June 2026, revenue grew 16.5%, EPS fell 100.0%, free cash flow grew 6.15% and total debt rose 44,345.3%, each against the same quarter a year earlier.
1.85
0.08
−4.15%
Follow CCLD
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
80.25 | 36.50 | 33.18 | 30.29 |
P/S ratio |
1.19 | 0.92 | 1.25 | 0.70 | |
P/FCF ratio |
7.69 | 5.37 | 8.04 | 4.60 | |
P/Operating CF |
18.47 | 12.72 | 42.93 | 12.74 | |
P/B ratio |
2.35 | 1.85 | 2.66 | 5.18 | |
Price to Tangible BV |
22.17 | 12.13 | 14.92 | 0.00 | |
EV/Sales |
1.22 | 0.91 | 1.24 | 0.91 | |
EV/EBITDA |
5.42 | 4.11 | 5.85 | 4.60 | |
EV/Operating CF |
5.56 | 3.82 | 5.67 | 4.37 | |
EV/FCF |
7.89 | 5.32 | 7.96 | 5.96 | |
Quick Ratio |
0.88 | 0.76 | 0.81 | 0.82 | |
Current Ratio |
1.26 | 1.05 | 1.11 | 1.02 | |
Net Debt/EBITDA |
0.19 | (0.52) | (0.71) | 4.41 | |
Debt/Assets |
7.43% | 0.50% | 0.29% | 40.73% | |
Debt/Equity |
0.12 | 0.01 | 0.00 | 2.20 | |
Asset Turnover |
1.42 | 1.51 | 1.55 | 1.52 | |
Operating CF/Net income |
4.35 | 5.70 | (8.15) | 39.08 | |
Capex/Depreciation |
(0.31) | (0.97) | (0.30) | (0.35) | |
Interest Coverage |
21.84 | 222.71 | 17.24 | 2.28 | |
Research and Development Expense of Revenue |
5.10% | 7.39% | 7.73% | 6.88% | |
Selling, General and Administrative Expense of Revenue |
19.35% | 18.17% | 22.10% | 20.92% | |
Intangible Assets out of Total Assets |
0.57 | 0.58 | 0.55 | 0.50 | |
Share Based Compensation of Revenue |
0.28% | 0.43% | 0.20% | 0.20% | |
Graham Net Nets |
(0.03) | (0.02) | (0.01) | (0.47) | |
Graham Number |
1.11 | 1.68 | 1.84 | 0.80 | |
Earnings Yield |
1.25% | 2.74% | 3.01% | 3.30% | |
Free Cash Flow Yield |
13.01% | 18.61% | 12.43% | 21.76% | |
Revenue per Share |
0.73 | 0.91 | 0.74 | 0.75 | |
Operating CF per Share |
0.17 | 0.23 | 0.09 | 0.17 | |
Capex per Share |
(0.04) | (0.08) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.13 | 0.15 | 0.06 | 0.14 | |
Cash per Share |
0.12 | 0.10 | 0.09 | 0.32 | |
Shareholders Equity per Share |
1.36 | 1.57 | 1.37 | 0.41 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.36 | 1.57 | 1.37 | 0.41 | |
Free Cash Flow |
5.67 | 5.81 | 2.38 | 5.75 | |
Working Capital |
6.06 | 1.32 | 2.63 | 0.70 | |
Capital Expenditures |
(1.70) | (2.87) | (1.23) | (1.32) | |
Net Current Asset Value |
(3.51) | (2.35) | (2.30) | (42.26) | |
EV/EBIT |
11.96 | 9.63 | 14.86 | 12.72 | |
Capex to Sales |
0.05 | 0.08 | 0.04 | 0.04 | |
Price to Operating Income |
11.64 | 9.73 | 15.02 | 9.80 | |
| Other line items | |||||
Average Receivables |
13.66 | 13.92 | 14.56 | 13.84 | |
Average Payables |
6.13 | 5.75 | 5.23 | 5.14 | |
Average Inventory |
0.56 | 0.54 | 0.52 | 0.50 | |
Average Assets |
80.64 | 79.61 | 80.14 | 84.55 | |
Average Common Equity |
52.15 | 54.64 | 56.25 | 36.74 |
Columns are period end dates